It was a venture fund called the Healthcare Investment Corporation that staked Dr. Venter $70 million in 1992 to create the Institute for Genomic Research, a nonprofit lab.
Healthcare Investment founded Human Genome Sciences to commercialize the institute's findings, and gave Dr. Venter stock in the company.